GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Research & Development

Praxsyn (Praxsyn) Research & Development : $0.00 Mil (TTM As of Sep. 2015)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Praxsyn's Research & Development for the three months ended in Sep. 2015 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2015 was $0.00 Mil.


Praxsyn Research & Development Historical Data

The historical data trend for Praxsyn's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Research & Development Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Praxsyn Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Praxsyn  (GREY:PXYN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Praxsyn Research & Development Related Terms

Thank you for viewing the detailed overview of Praxsyn's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.

Praxsyn (Praxsyn) Headlines